| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $26.2B | $25.1B | $23.7B | $20.8B | $13.9B | $2.2B | $5.4B | $5.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $4.1B | $3.8B | $3.9B | $3.5B | $1.8B | $-0.1B | $0.3B | $0.4B |
| Net Income | $2.6B | $2.4B | $3.1B | $2.4B | $1.1B | $-0.2B | $0.3B | $0.3B |
| EPS (Basic) | $9.53 | $8.36 | $10.23 | $7.27 | $3.36 | $-0.50 | $0.85 | $0.93 |
| EPS (Diluted) | $9.51 | $8.33 | $10.18 | $7.24 | $3.34 | $-0.50 | $0.85 | $0.92 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $27.5B | $26.2B | $25.7B | $24.8B | $25.6B | $24.7B | $25.1B | $23.7B |
| Current Assets | $3.6B | $3.5B | $3.3B | $3.3B | $3.6B | $2.8B | $3.1B | $2.7B |
| Cash & Equivalents | $0.4B | $0.4B | $0.3B | $0.5B | $1.4B | $0.9B | $0.2B | $0.3B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $8.4B | $8.6B | $7.8B | $7.3B | $6.4B | $5.8B | $6.7B | $6.4B |
| Stockholders' Equity | $-3.8B | $-3.0B | $-0.7B | $0.6B | $1.4B | $0.4B | $0.7B | $2.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.2B | $2.7B | $3.2B | $2.4B | $1.2B | $1.6B | $1.7B | $2.4B |
| Investing Cash Flow | $-0.9B | $-0.7B | $-0.5B | $-0.3B | $-0.2B | $0.0B | $-0.3B | $-0.1B |
| Capital Expenditures | — | $0.8B | $0.5B | $0.3B | $0.2B | $0.1B | $0.7B | $0.6B |
| Financing Cash Flow | $-2.3B | $-2.0B | $-2.9B | $-3.0B | $-0.5B | $-1.0B | $-1.5B | $-2.4B |